台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

健亞

(4130)
可現股當沖
  • 股價
    19.95
  • 漲跌
    ▼0.05
  • 漲幅
    -0.25%
  • 成交量
    52
  • 產業
    上櫃 生技醫療類股
  • 151人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
健亞 (4130)籌碼相關-元大-崇德 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2603/1003/2003/3004/1204/221820222426May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

元大-崇德 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/1700.00120.2520.30-1397-0.25%
2025/04/10119.950.220.5020.650.93930.22%
2025/04/0900.001018.7918.80-10388-2.57%
2025/04/0700.00119.4519.50-1376-0.27%
2025/03/26121.8500.0021.8013640.27%
2025/03/25022.7500.0021.9003640.00%
2025/03/24022.7000.0023.0003350.00%
2025/03/10023.8500.0023.6503340.00%
2025/03/07223.7000.0023.7023340.60%
2025/03/06023.9000.0023.8003340.00%
2025/03/0500.002023.7123.75-20334-5.98%
2025/03/0400.00323.6323.60-3334-0.90%
2025/03/0300.00823.4423.35-8334-2.39%
2025/02/2600.00124.0023.95-1330-0.30%
2025/02/2500.005724.0724.10-57330-17.24%
2025/02/2400.00124.4024.30-1328-0.30%
2025/02/2100.00224.1324.05-2326-0.61%
2025/02/17524.5200.0024.2553251.54%
2025/02/14423.8500.0024.1043221.24%
2025/02/13223.7500.0023.6523200.62%
2025/02/1000.00123.7523.55-1316-0.32%
2025/02/07123.7000.0023.7513120.32%
2025/02/0600.000.723.4523.45-0.7309-0.24%
2025/02/0400.00323.1523.25-3303-0.99%
2025/01/22023.85723.8323.90-7294-2.36%
2025/01/202024.62523.9423.70152835.29%
2025/01/1732.225.2600.0025.2032.225412.67%
2025/01/161724.241724.8625.3002250.00%
2025/01/15724.5900.0024.8571873.74%
2025/01/1000.001621.3521.15-1686-18.45%
2024/12/3100.00620.8420.80-686-6.93%
2024/12/3000.00620.9020.90-688-6.75%
2024/12/20020.8000.0020.750960.00%
2024/12/16321.2500.0021.203963.10%
2024/12/04721.8500.0021.957977.19%
2024/11/1100.005.422.3022.30-5.4108-4.94%
2024/11/04122.2500.0022.2011270.78%
2024/10/2900.000.222.6022.45-0.2141-0.14%
2024/10/251322.4500.0022.40131448.97%
2024/10/24122.70122.9022.7001460.00%
2024/10/220.222.7000.0022.450.21460.10%
2024/10/2100.00622.3822.35-6149-4.01%
2024/10/1800.001.222.2622.25-1.2153-0.78%
2024/10/1700.00422.2822.30-4158-2.52%
2024/10/1600.000.122.2022.15-0.1160-0.06%
2024/10/1400.00122.0522.20-1165-0.60%
2024/10/110.322.40022.7022.350.21660.15%
2024/10/09122.6500.0022.4011690.59%
2024/10/08322.971.722.8822.751.31690.79%
2024/10/0700.00123.1423.10-1176-0.55%
2024/10/0100.000.222.9523.00-0.2178-0.11%
2024/09/2700.00122.9022.95-1179-0.56%
2024/09/2600.00222.8022.75-2180-1.11%
2024/09/2000.00122.3522.35-1191-0.52%
2024/09/1900.00122.2522.30-1193-0.52%
2024/09/0300.00122.4022.25-1209-0.48%
2024/09/0200.00122.8022.10-1208-0.48%
2024/08/2900.00122.5022.60-1208-0.48%
2024/08/2800.00222.5322.55-2210-0.95%
2024/08/2700.00322.2322.30-3213-1.41%
2024/08/2600.00422.3622.40-4213-1.87%
2024/08/2300.00122.2522.35-1215-0.46%
2024/08/2200.00122.4522.35-1215-0.46%
2024/08/1900.00222.8522.95-2216-0.92%
2024/08/16122.7000.0022.7512170.46%
2024/08/1500.000.222.5522.55-0.2218-0.09%
2024/08/1400.000.222.2022.45-0.2221-0.08%
2024/08/09122.7000.0022.5512240.44%
2024/08/0800.00122.5522.60-1226-0.44%
2024/08/0700.001522.3722.35-15226-6.62%
2024/07/19124.1500.0023.9012110.47%
2024/07/1800.000.224.3024.40-0.2209-0.07%
2024/07/12124.0500.0024.1012040.49%
2024/07/0800.00124.6524.60-1204-0.49%
2024/07/0500.00124.6024.75-1206-0.48%
2024/07/0300.00124.7524.75-1206-0.48%
2024/06/270.124.8500.0024.700.12010.05%
2024/06/26024.7500.0024.6501950.02%
2024/06/20224.45124.4524.4011900.52%
2024/06/1800.00124.7524.60-1189-0.53%
2024/06/17124.7500.0024.8011900.52%
2024/06/1400.00124.5524.65-1188-0.53%
2024/06/1200.00224.4024.30-2189-1.05%
2024/06/0700.00324.2524.25-3189-1.58%
2024/06/06324.2200.0024.2531911.57%
2024/06/05124.35124.2524.3501930.00%
2024/06/0300.00124.1024.25-1200-0.50%
2024/05/3100.00124.0524.05-1201-0.50%
2024/05/2800.00224.2024.25-2205-0.97%
2024/05/2300.00124.1023.95-1204-0.49%
2024/05/2200.00124.1524.10-1206-0.48%
2024/05/1600.00323.9323.90-3219-1.36%
2024/05/1400.003.123.8423.90-3.1225-1.38%
2024/05/0200.00124.5024.45-1217-0.46%
2024/04/24124.3500.0024.3012150.46%
2024/04/23424.1500.0024.2542181.83%
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章